Submitted by admin on September 24, 2024 - 11:59am
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Inside the GLP-1 'price war'
Novartis inks $1B-plus biobucks deal with Flagship's Generate
Eli Lilly's Alzheimer's drug approved in Japan
*please scroll down for all the latest news*